Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology crawled date : 2022 - 02 - 15 save search
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
NKTX | $7.16 -5.29% -5.59% 680K
|
Health Technology
|
| O: 1.9%
H: 4.42%
C: 2.94%
CRSP | News M | $55.66 -1.33% -1.35% 910K
|
Health Technology
|
| O: 2.37%
H: 2.27%
C: 1.62%
financial results therapeutics crispr report results
INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
SANA | $8.58 6.06% 5.71% 1.2M
|
|
| O: 2.07%
H: 4.63%
C: 3.76%
SGTX | $22.47 -2.56% 0.0% 0
|
Health Technology
|
| O: -0.62%
H: 5.62%
C: 1.87%
PPG A | $130.52 0.07% 0.0% 1.6M
|
Process Industries
|
| O: 1.67%
H: 0.76%
C: -0.09%
MCRB | $0.7295 -4.01% -4.18% 5.8M
|
Health Technology
|
| O: 1.27%
H: 7.38%
C: 5.5%
RUBY | $0.057 -99.3% 760K
|
Health Technology
|
| O: 2.87%
H: 3.49%
C: 0.52%
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 0.01%
H: 7.33%
C: 6.06%
FHTX | $5.21 0.97% 0.96% 110K
|
Health Technology
|
| O: 3.91%
H: 0.0%
C: -4.07%
EVLO | $0.3165 -87.39% 710K
|
Health Technology
|
| O: 0.77%
H: 8.38%
C: 2.28%
DNLI | $15.55 -3.48% -3.6% 940K
|
Health Technology
|
| O: 1.58%
H: 3.53%
C: 0.59%
CDAK | $0.057 -55.99% -131.25% 0
|
Health Technology
|
| O: 2.7%
H: 4.66%
C: 4.05%
AXLA | $4.58 -56.33% 42K
|
Health Technology
|
| O: 2.99%
H: 3.49%
C: 3.49%
grant granted
U.S. Food and Drug Administration (FDA) Accepts Mirati Therapeutics' New Drug Application for Adagrasib as Treatment of Previously Treated KRASG12C-Mutated Non-Small Cell Lung Cancer
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 1.42%
H: 5.52%
C: 4.35%
krasg12 new drug treatment fda application drug therapeutics cel food lung cancer cancer fda acceptance
How far we’ve come part 3 – animal genomics
Published: 2022-02-15 (Crawled : 23:00) - pacb.com
PACB | $1.355 -7.82% -8.49% 11M
|
Health Technology
|
| O: -9.05%
H: 15.56%
C: 14.78%
genomics genomic
Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
CSBR | $5.03 -0.79% -0.8% 1.4K
|
Health Technology
|
| O: 2.2%
H: 8.09%
C: 4.18%
react partnership cel active t-cell
Coherus Names Paul Reider Chief Commercial Officer
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.24%
H: 1.47%
C: 0.98%
CHRS | $2.03 -6.88% -7.39% 720K
|
Health Technology
|
| O: 0.77%
H: 2.82%
C: 0.53%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.33%
H: 0.52%
C: -0.47%
commercialization
Twist Bioscience Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
TWST | $30.81 -2.19% -2.24% 1.4M
|
Health Technology
|
| O: 2.82%
H: 5.53%
C: 5.16%
offering ces bioscience
Jazz Pharmaceuticals to Report 2021 Fourth Quarter and Full Year Financial Results on March 1, 2022
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
JAZZ | $108.38 -1.18% -1.19% 400K
|
Health Technology
|
| O: 0.08%
H: 2.83%
C: 1.44%
als financial results report results
Moore Kuehn Encourages BDSI, ZWS, EYES, and GIIX Investors to Contact Law Firm
Published: 2022-02-15 (Crawled : 23:00) - prnewswire.com
ZWS S | $32.12 -1.92% 0.0% 1.8M
|
Manufacturing
|
| O: -0.43%
H: 2.29%
C: -0.77%
GIIX | $10.06 0.0%
|
|
| O: 0.4%
H: 0.0%
C: -0.4%
EYES | $4.14 -0.24% 3.14%
|
Health Technology
|
| O: 0.0%
H: 3.65%
C: 2.92%
eye yes
Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors
Published: 2022-02-15 (Crawled : 22:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.49%
H: 0.81%
C: 0.43%
air one
PERRIGO TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2021 FINANCIAL RESULTS ON MARCH 1, 2022
Published: 2022-02-15 (Crawled : 22:00) - prnewswire.com
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: -0.11%
H: 2.11%
C: 1.47%
financial results results
HOOKIPA and Gilead Amend Collaboration and License Agreement to Develop Immunotherapies Against HIV
Published: 2022-02-15 (Crawled : 22:00) - biospace.com/
HOOK | $0.843 10.2% 9.25% 10M
|
Health Technology
|
| O: 3.17%
H: 4.62%
C: 3.08%
license collaboration hiv immunotherapy
AVITA Medical to Announce Transition Period July 1, 2021 to December 31, 2021 Financial Results
Published: 2022-02-15 (Crawled : 21:00) - globenewswire.com
RCEL | $8.58 -4.45% -4.66% 150K
|
Health Technology
|
| O: -0.99%
H: 0.56%
C: 0.11%
financial results results
Renibus Therapeutics Announces Appointment of Frank Stonebanks as CEO and $35 Million Series A Funding
Published: 2022-02-15 (Crawled : 18:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.32%
H: 1.19%
C: 0.71%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.0%
H: 0.99%
C: 0.47%
ces ceo therapeutics funding one
Horizon Therapeutics plc Partners with the Doug the Pug Foundation and Sing Me A Story Foundation to Bring Awareness to Rare Diseases Impacting Children through #RAREis Playlist
Published: 2022-02-15 (Crawled : 18:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 1.72%
H: 1.0%
C: 0.02%
rare therapeutics disease children
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-15 (Crawled : 17:00) - prnewswire.com
AVNS | $18.71 -0.27% 0.0% 170K
|
Health Technology
|
| O: 1.88%
H: 1.04%
C: 0.19%
financial results conference results
Stryker to participate in Cowen 42nd Annual Health Care Conference
Published: 2022-02-15 (Crawled : 17:00) - globenewswire.com
SYK | $336.85 0.58% 0.0% 1.5M
|
Health Technology
|
| O: 1.7%
H: 2.03%
C: 1.57%
health conference
Thermo Fisher Scientific Introduces New Cell and Gene Therapy Integrated Commercial Packaging and Distribution Services
Published: 2022-02-15 (Crawled : 16:00) - biospace.com/
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: 1.12%
H: 0.66%
C: -1.9%
gene therapy distribution cel services therapy commercialization
Investors Go with Their Gut, Dropping $236M into Kallyope
Published: 2022-02-15 (Crawled : 16:00) - biospace.com/
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 1.57%
H: 2.63%
C: 1.36%
drop
Insights on the Agricultural Biotechnology for Transgenic Crops Global Market to 2026 - Featuring Agrilife, Bayer and Evogene Among Others
Published: 2022-02-15 (Crawled : 16:00) - prnewswire.com
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 1.63%
H: 3.2%
C: 1.6%
technology agricultural biotech iot drop
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.